Behavioural Brain Research, ISSN 0166-4328, 06/2019, Volume 365, pp. 48 - 55
Mesenchymal stem cell transplantation can regulate neuroinflammation and treat Alzheimer's disease (AD), but its effect is attenuated by in vitro expansion. To...
Mesenchymal stem cell | Tanshinone IIA | Neuroinflammation | Alzheimer's disease
Mesenchymal stem cell | Tanshinone IIA | Neuroinflammation | Alzheimer's disease
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 06/2019, Volume 365, pp. 48 - 55
Mesenchymal stem cell transplantation can regulate neuroinflammation and treat Alzheimer's disease (AD), but its effect is attenuated by in vitro expansion. To...
Mesenchymal stem cell | Tanshinone IIA | Neuroinflammation | Alzheimer’s disease | Index Medicus
Mesenchymal stem cell | Tanshinone IIA | Neuroinflammation | Alzheimer’s disease | Index Medicus
Journal Article
CHEMICAL SCIENCE, ISSN 2041-6520, 05/2019, Volume 10, Issue 17, pp. 4667 - 4672
Acute lung injury (ALI) is an inflammatory disease with no effective pharmacological treatment. The therapeutic potential of the anti-inflammatory natural...
ABSORPTION | DERIVATIVES | CHEMISTRY, MULTIDISCIPLINARY | RESPIRATORY-DISTRESS-SYNDROME | TANSHINONE-IIA
ABSORPTION | DERIVATIVES | CHEMISTRY, MULTIDISCIPLINARY | RESPIRATORY-DISTRESS-SYNDROME | TANSHINONE-IIA
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 2009, Volume 158, Issue 5, pp. 1227 - 1235
Journal Article
5.
Full Text
Site-selective Csp3-H aryloxylation of natural product Tanshinone IIA and its analogues
Tetrahedron Letters, ISSN 0040-4039, 05/2017, Volume 58, Issue 19, pp. 1822 - 1825
A novel catalyst-free Csp -H aryloxylation approach allowing for rapid installation of a wide range of aryloxyl groups regioselectively at the C-4 position of...
Natural product | Tanshinone IIA | Chemical modification | C-H activation | Aryloxylation
Natural product | Tanshinone IIA | Chemical modification | C-H activation | Aryloxylation
Journal Article
International Journal of Biological Sciences, ISSN 1449-2288, 2011, Volume 7, Issue 3, pp. 383 - 389
Journal Article
Chemosphere, ISSN 0045-6535, 03/2020, Volume 243, p. 125373
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 12/2019, Volume 520, Issue 3, pp. 580 - 585
Diabetes is a strong risk factor of peripheral arterial disease (PAD), and also leads to impaired perfusion recovery in the ischemic limb, which eventually...
Sodium Tanshinone IIA sulfonate | Angiogenesis | Reactive oxygen species | Diabetes | Peripheral Arterial Disease
Sodium Tanshinone IIA sulfonate | Angiogenesis | Reactive oxygen species | Diabetes | Peripheral Arterial Disease
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 11/2019
Journal Article
Archives of Biochemistry and Biophysics, ISSN 0003-9861, 11/2019, Volume 677, p. 108154
The proliferation and migration of vascular smooth muscle cells (VSMCs) play important roles in the development and progression of diabetes-related vascular...
microRNAs | Tanshinone IIA | Tropomyosin 1 | Vascular smooth muscle cells | High glucose
microRNAs | Tanshinone IIA | Tropomyosin 1 | Vascular smooth muscle cells | High glucose
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 09/2019, Volume 234, Issue 9, pp. 15420 - 15428
Tanshinone IIA is a lipophilic diterpene extracted from the Salvia miltiorrhiza bunge, possessing antiapoptotic and antioxidant activities. The purpose of this...
lncRNA ANRIL | NF‐κB signaling | tanshinone IIA | cataract | hydrogen peroxide | NF-κB signaling
lncRNA ANRIL | NF‐κB signaling | tanshinone IIA | cataract | hydrogen peroxide | NF-κB signaling
Journal Article
Life Sciences, ISSN 0024-3205, 11/2019, p. 117085
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 12/2019, Volume 137, pp. 59 - 70
Ventricular remodeling is a major pathological process of normal heart failure. With the aging of society, poor diet control, social, psychological and other...
Ventricar remodeling | Tanshinone IIA | Myocardial ischemia | Inflammatory cells | Puerarin | Compatibility
Ventricar remodeling | Tanshinone IIA | Myocardial ischemia | Inflammatory cells | Puerarin | Compatibility
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 01/2020, Volume 30, Issue 1, p. 126780
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 08/2016, Volume 235, pp. 34 - 47
The blood–brain barrier (BBB) is a vital boundary between neural tissue and circulating blood. The BBB's unique and protective features control brain...
Nanoparticles | Brain repair | Stroke | Parkinson's disease | Alzheimer's disease | Blood–brain barrier | Blood-brain barrier | P-GLYCOPROTEIN FUNCTION | GOLD NANOPARTICLES | ALZHEIMERS-DISEASE | REPERFUSION INJURY | CHEMISTRY, MULTIDISCIPLINARY | TANSHINONE IIA NANOPARTICLES | TIGHT JUNCTIONS | CIRCUMVENTRICULAR ORGANS | POLYMERIC NANOPARTICLES | IN-VITRO MODEL | PHARMACOLOGY & PHARMACY | PARKINSONS-DISEASE | Brain - metabolism | Animals | Biological Transport | Nanoparticles - therapeutic use | Humans | Nanoparticles - administration & dosage | Neurodegenerative Diseases - metabolism | Neurodegenerative Diseases - drug therapy | Drug Delivery Systems | Drugs | Drug delivery systems | Nervous system diseases | Vehicles
Nanoparticles | Brain repair | Stroke | Parkinson's disease | Alzheimer's disease | Blood–brain barrier | Blood-brain barrier | P-GLYCOPROTEIN FUNCTION | GOLD NANOPARTICLES | ALZHEIMERS-DISEASE | REPERFUSION INJURY | CHEMISTRY, MULTIDISCIPLINARY | TANSHINONE IIA NANOPARTICLES | TIGHT JUNCTIONS | CIRCUMVENTRICULAR ORGANS | POLYMERIC NANOPARTICLES | IN-VITRO MODEL | PHARMACOLOGY & PHARMACY | PARKINSONS-DISEASE | Brain - metabolism | Animals | Biological Transport | Nanoparticles - therapeutic use | Humans | Nanoparticles - administration & dosage | Neurodegenerative Diseases - metabolism | Neurodegenerative Diseases - drug therapy | Drug Delivery Systems | Drugs | Drug delivery systems | Nervous system diseases | Vehicles
Journal Article
BEHAVIOURAL BRAIN RESEARCH, ISSN 0166-4328, 06/2019, Volume 365, pp. 48 - 55
Mesenchymal stem cell transplantation can regulate neuroinflammation and treat Alzheimer's disease (AD), but its effect is attenuated by in vitro expansion. To...
Mesenchymal stem cell | Tanshinone IIA | ALZHEIMERS-DISEASE | Neuroinflammation | BEHAVIORAL SCIENCES | Alzheimer's disease | NEUROSCIENCES
Mesenchymal stem cell | Tanshinone IIA | ALZHEIMERS-DISEASE | Neuroinflammation | BEHAVIORAL SCIENCES | Alzheimer's disease | NEUROSCIENCES
Journal Article
International Journal of Biochemistry and Cell Biology, ISSN 1357-2725, 02/2019, Volume 107, pp. 82 - 91
Endoplasmic reticulum (ER) stress caused by β-amyloid protein (Aβ) may play an important role in the pathogenesis of Alzheimer disease (AD). Our previous data...
β-amyloid protein | Tanshinone IIA | Alzheimer disease | Endoplasmic reticulum stress | Apoptosis | Index Medicus
β-amyloid protein | Tanshinone IIA | Alzheimer disease | Endoplasmic reticulum stress | Apoptosis | Index Medicus
Journal Article
American Journal of Translational Research, ISSN 1943-8141, 2019, Volume 11, Issue 5, pp. 3140 - 3149
Peripheral neurotoxicity is a common adverse reaction in cancer patients undergoing chemotherapy. The neuropathologic changes were partly associated with...
Tanshinone IIA | Chemotherapy | Neurotoxicity | Autophagy
Tanshinone IIA | Chemotherapy | Neurotoxicity | Autophagy
Journal Article
International Immunopharmacology, ISSN 1567-5769, 11/2019, p. 105968
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 01/2020, Volume 121, p. 109586
Transforming growth factor-β 1 (TGF-β1) is a key mediator in fibrogenesis, and is upregulated and activated in fibrotic diseases. The exact role of TGF-β1-Smad...
Tanshinone IIA | Smad | Pulmonary fibrosis | Silicosis | Transforming growth factor-beta 1
Tanshinone IIA | Smad | Pulmonary fibrosis | Silicosis | Transforming growth factor-beta 1
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.